• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金色动孢菌DSM 44650产生的糖肽类抗生素动霉素中的一种罕见肽支架。

A rare peptide scaffold in kineomicins, the glycopeptide antibiotics produced by Actinokineospora auranticolor DSM 44650.

作者信息

Yushchuk Oleksandr, Berini Francesca, Zhong Lei, Rückert-Reed Christian, Bernasconi Elena, Bartolone Letizia, Busche Tobias, Kalinowski Jörn, Süssmuth Roderich D, Marinelli Flavia

机构信息

Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, Hrushevskoho St. 4, 79005, Lviv, Ukraine.

Department of Biotechnology and Life Sciences, University of Insubria, via J. H. Dunant 3, 21100, Varese, Italy.

出版信息

Commun Chem. 2025 May 3;8(1):134. doi: 10.1038/s42004-025-01534-x.

DOI:10.1038/s42004-025-01534-x
PMID:40319198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049478/
Abstract

Discovery of novel antibiotics is crucial to counteract bacterial resistance spread. Aiming to expand the available arsenal of last-resort glycopeptide antibiotics (GPAs), we mined the actinobacterial genomes of Pseudonocardiales. We thus identified a biosynthetic gene cluster (BGC) encoding for a GPA with a novel peptide scaffold, not fitting into the existing classification of GPA types. By cultivating the producer strain, Actinokineospora auranticolor DSM 44650, an antibiotic complex-named kineomicins (Kmc)-was identified and characterized by microbiological assays, LC-MS, and MS/MS analyses. A comprehensive model for Kmc biosynthesis was then proposed by a thorough investigation of kineomicin BGC (knm). The structure of the main complex congener (KmcB), resolved by NMR spectroscopy, proved to be unique. Finally, the remarkably high antibiotic production rate, up to >1 g L Kmc in benchtop bioreactor, indicated A. auranticolor as a natural GPA overproducer, holding promise as a potential host for heterologous expression of GPA BGCs.

摘要

发现新型抗生素对于对抗细菌耐药性传播至关重要。为了扩充可用的最后手段糖肽类抗生素(GPA)储备,我们挖掘了诺卡氏菌目的放线菌基因组。因此,我们鉴定出一个生物合成基因簇(BGC),其编码一种具有新型肽支架的GPA,不符合现有的GPA类型分类。通过培养产生菌菌株——金色动孢菌DSM 44650,一种名为动霉素(Kmc)的抗生素复合物被鉴定出来,并通过微生物学测定、液相色谱-质谱联用(LC-MS)和串联质谱(MS/MS)分析进行了表征。通过对动霉素生物合成基因簇(knm)的深入研究,随后提出了一个Kmc生物合成的综合模型。通过核磁共振光谱解析的主要复合物同源物(KmcB)的结构被证明是独特的。最后,在台式生物反应器中高达>1 g/L Kmc的显著高抗生素生产率表明,金色动孢菌是一种天然的GPA高产菌,有望成为GPA BGC异源表达的潜在宿主。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/9e911c00e39f/42004_2025_1534_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/1c5ba1e5bc4b/42004_2025_1534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/5f767e13443e/42004_2025_1534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/0c5b3ba65fce/42004_2025_1534_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/ff0e2086fa11/42004_2025_1534_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/9e911c00e39f/42004_2025_1534_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/1c5ba1e5bc4b/42004_2025_1534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/5f767e13443e/42004_2025_1534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/0c5b3ba65fce/42004_2025_1534_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/ff0e2086fa11/42004_2025_1534_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b566/12049478/9e911c00e39f/42004_2025_1534_Fig5_HTML.jpg

相似文献

1
A rare peptide scaffold in kineomicins, the glycopeptide antibiotics produced by Actinokineospora auranticolor DSM 44650.金色动孢菌DSM 44650产生的糖肽类抗生素动霉素中的一种罕见肽支架。
Commun Chem. 2025 May 3;8(1):134. doi: 10.1038/s42004-025-01534-x.
2
Glycopeptide Antibiotic Resistance Genes: Distribution and Function in the Producer Actinomycetes.糖肽类抗生素抗性基因:在产生放线菌中的分布与功能
Front Microbiol. 2020 Jun 17;11:1173. doi: 10.3389/fmicb.2020.01173. eCollection 2020.
3
Complete Genome Assembly of DSM 45807 Allows the Characterization of a Novel Glycopeptide Biosynthetic Gene Cluster.DSM 45807的全基因组组装使得一个新型糖肽生物合成基因簇得以表征。
Genes (Basel). 2024 Dec 22;15(12):1651. doi: 10.3390/genes15121651.
4
Genomic-Led Discovery of a Novel Glycopeptide Antibiotic by DSM 45129.基于基因组的发现:DSM 45129 产生新型糖肽类抗生素
ACS Chem Biol. 2021 May 21;16(5):915-928. doi: 10.1021/acschembio.1c00170. Epub 2021 Apr 29.
5
Genomic Insights into the Distribution and Phylogeny of Glycopeptide Resistance Determinants within the Phylum.关于糖肽抗性决定簇在该门内的分布和系统发育的基因组学见解。
Antibiotics (Basel). 2021 Dec 14;10(12):1533. doi: 10.3390/antibiotics10121533.
6
Heterologous Expression Reveals Ancient Properties of Tei3—A VanS Ortholog from the Teicoplanin Producer Actinoplanes teichomyceticus.异源表达揭示了 Tei3 的古老特性——来自泰乐菌素产生放线菌 Actinoplanes teichomyceticus 的 VanS 同源物。
Int J Mol Sci. 2022 Dec 11;23(24):15713. doi: 10.3390/ijms232415713.
7
Newest perspectives of glycopeptide antibiotics: biosynthetic cascades, novel derivatives, and new appealing antimicrobial applications.糖肽类抗生素的最新研究进展:生物合成途径、新型衍生物和新的有吸引力的抗菌应用。
World J Microbiol Biotechnol. 2023 Jan 3;39(2):67. doi: 10.1007/s11274-022-03512-0.
8
Mining biosynthetic gene clusters in Paenibacillus genomes to discover novel antibiotics.从类芽孢杆菌基因组中挖掘生物合成基因簇以发现新型抗生素。
BMC Microbiol. 2024 Jun 27;24(1):226. doi: 10.1186/s12866-024-03375-5.
9
GPAHex-A synthetic biology platform for Type IV-V glycopeptide antibiotic production and discovery.GPAHex—一种用于 IV-V 型糖肽类抗生素生产和发现的合成生物学平台。
Nat Commun. 2020 Oct 16;11(1):5232. doi: 10.1038/s41467-020-19138-5.
10
How To Make a Glycopeptide: A Synthetic Biology Approach To Expand Antibiotic Chemical Diversity.如何制备糖肽:一种扩展抗生素化学多样性的合成生物学方法。
ACS Infect Dis. 2016 Sep 9;2(9):642-650. doi: 10.1021/acsinfecdis.6b00105. Epub 2016 Aug 5.

本文引用的文献

1
Complete Genome Assembly of DSM 45807 Allows the Characterization of a Novel Glycopeptide Biosynthetic Gene Cluster.DSM 45807的全基因组组装使得一个新型糖肽生物合成基因簇得以表征。
Genes (Basel). 2024 Dec 22;15(12):1651. doi: 10.3390/genes15121651.
2
Resurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides.复活古老抗生素:揭示现代靶向脂类 II 的糖肽的起源。
Nat Commun. 2023 Nov 29;14(1):7842. doi: 10.1038/s41467-023-43451-4.
3
Metabolic engineering of the shikimate pathway in Amycolatopsis strains for optimized glycopeptide antibiotic production.
在 Amycolatopsis 菌株中对莽草酸途径进行代谢工程改造,以优化糖肽类抗生素的生产。
Metab Eng. 2023 Jul;78:84-92. doi: 10.1016/j.ymben.2023.05.005. Epub 2023 May 25.
4
antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation.antiSMASH 7.0:用于检测、调控、化学结构和可视化的全新且改进的预测功能。
Nucleic Acids Res. 2023 Jul 5;51(W1):W46-W50. doi: 10.1093/nar/gkad344.
5
Cross-Talking of Pathway-Specific Regulators in Glycopeptide Antibiotics (Teicoplanin and A40926) Production.糖肽类抗生素(替考拉宁和A40926)生产中特定途径调节因子的相互作用
Antibiotics (Basel). 2023 Mar 24;12(4):641. doi: 10.3390/antibiotics12040641.
6
Occurrence of and Related Genes beyond the Phylum.超越 门的 和相关基因的发生。
Genes (Basel). 2022 Oct 27;13(11):1960. doi: 10.3390/genes13111960.
7
Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteria.超越万古霉素:改良、改造、生产和发现改进型糖肽类抗生素以应对多药耐药菌的最新进展。
Curr Opin Biotechnol. 2022 Oct;77:102767. doi: 10.1016/j.copbio.2022.102767. Epub 2022 Aug 4.
8
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.近年来半合成糖肽类抗生素的研究进展:2014-2022 年。
ACS Infect Dis. 2022 Aug 12;8(8):1381-1407. doi: 10.1021/acsinfecdis.2c00253. Epub 2022 Jul 27.
9
Phylogeny-Informed Synthetic Biology Reveals Unprecedented Structural Novelty in Type V Glycopeptide Antibiotics.系统发育信息指导的合成生物学揭示了V型糖肽类抗生素前所未有的结构新颖性。
ACS Cent Sci. 2022 May 25;8(5):615-626. doi: 10.1021/acscentsci.1c01389. Epub 2022 Apr 27.
10
Genomic Insights into the Distribution and Phylogeny of Glycopeptide Resistance Determinants within the Phylum.关于糖肽抗性决定簇在该门内的分布和系统发育的基因组学见解。
Antibiotics (Basel). 2021 Dec 14;10(12):1533. doi: 10.3390/antibiotics10121533.